Abstract
Level of interleukin 6 (IL-6) is associated with fracture healing. This study was performed to explore the effect of IL-6 blockade on fracture healing. Clinical serum levels of IL-6 and tumor necrosis factor-α (TNF-α) were evaluated by enzyme-linked immunosorbent assay (ELISA). For animal experiments, the IL-6 levels after fracture and treatment with rat anti-mouse IL-6 receptor antibody (MR16-1) were assessed. Then, mice were assigned into four or seven groups: control group, fracture group, isotype IgG group, and MR16-1 groups. Serum levels of IL-6 and TNF-α, relative flexural rigidity, and mRNA levels of osteoblast-specific genes were respectively assayed by ELISA, three-point bending test, and quantitative reverse transcription PCR (qRT-PCR). Serum levels of IL-6 and TNF-α after fracture in humans and mice were increased. The increase in IL-6 and TNF-α levels in murine serum was attenuated by MR16-1 treatment. The three-point bending test showed the relative flexural rigidity of the femur was decreased after fracture, whereas the decrease was alleviated by MR16-1 treatment. The qRT-PCR results demonstrated mRNA levels of osteoblast-specific genes were upregulated after fracture and then further upregulated by MR16-1 treatment in a dose-dependent manner. Collectively, the serum level of IL-6 was elevated after fracture both in clinical and murine samples. IL-6 blockade by MR16-1 promoted fracture healing, which might be associated with changes in expression of osteoblast-specific genes.
Similar content being viewed by others
References
Gardner, M. J., Demetrakopoulos, D., Shindle, M. K., Griffith, M. H., and Lane, J. M. (2006) Osteoporosis and skeletal fractures, HSS J., 2, 62–69.
Healy, W. L., and Iorio, R. (2004) Total hip arthroplasty: optimal treatment for displaced femoral neck fractures in elderly patients, Clin. Orthopaed. Rel. Res., 429, 43–48.
Xia, W. B., He, S. L., Xu, L., Liu, A. M., Jiang, Y., Li, M., Wang, O., Xing, X. P., Sun, Y., and Cummings, S. R. (2012) Rapidly increasing rates of hip fracture in Beijing, China, J. Bone Mineral Res., 27, 125–129.
Cauley, J. A. (2013) Public health impact of osteoporosis, J. Gerontol., 68, 1243–1251.
Rozen, N., Lewinson, D., Bick, T., Meretyk, S., and Soudry, M. (2007) Role of bone regeneration and turnover modulators in control of fracture, Crit. Rev. Eukaryot. Gene Express., 17, 197–213.
Kolar, P., Schmidt-Bleek, K., Schell, H., Gaber, T., Toben, D., Schmidmaier, G., Perka, C., Buttgereit, F., and Duda, G. N. (2010) The early fracture hematoma and its potential role in fracture healing, Tissue Eng. Part B Rev., 16, 427–434.
Aho, A. J. (1966) Electron microscopic and histological observations on fracture repair in young and old rats, Acta Pathol. et Microbiol. Scandinavica, 184, 9.
Chung, R., Cool, J. C., Scherer, M. A., Foster, B. K., and Xian, C. J. (2006) Roles of neutrophil-mediated inflammatory response in the bony repair of injured growth plate cartilage in young rats, J. Leukoc. Biol., 80, 1272–1280.
Bastian, O., Pillay, J., Alblas, J., Leenen, L., Koenderman, L., and Blokhuis, T. (2011) Systemic inflammation and fracture healing, J. Leukoc. Biol., 89, 669–673.
Sun, M., Yang, J., Wang, J., Hao, T., Jiang, D., Bao, G., and Liu, G. (2016) TNF-α is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose, Cytokine, 80, 35–42.
Gerstenfeld, L. C., Cullinane, D. M., Barnes, G. L., Graves, D. T., and Einhorn, T. A. (2003) Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation, J. Cell. Biochem., 88, 873–884.
Hong, D. S., Angelo, L. S., and Razelle, K. (2007) Interleukin-6 and its receptor in cancer, Cancer, 110, 1911–1928.
Kimura, A., and Kishimoto, T. (2010) IL-6: regulator of Treg/Th17 balance, Eur. J. Immunol., 40, 1830–1835.
Moran, A., Thacker, S. A., Arikan, A. A., Mastrangelo, M. A., Wu, Y., Yu, B., and Tweardy, D. J. (2011) IL-6-mediated activation of Stat3α prevents trauma/hemorrhagic shock-induced liver inflammation, PLoS One, 6, e21449–e21449.
Andreas, K., Lubke, C., Haupl, T., Dehne, T., Morawietz, L., Ringe, J., Kaps, C., and Sittinger, M. (2008) Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study, Arthrit. Res. Ther., 10, R9.
Li, Y., Backesjo, C. M., Haldosen, L. A., and Lindgren, U. (2008) IL-6 receptor expression and IL-6 effects change during osteoblast differentiation, Cytokine, 43, 165–173.
Yang, X., Ricciardi, B. F., Hernandez-Soria, A., Shi, Y., Camacho, N. P., and Bostrom, M. P. G. (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice, Bone, 41, 928–936.
Choy, E. H., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., and Price, R. (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial, Arthrit. Rheum., 46, 3143.
Fujita, R., Kawano, F., Ohira, T., Nakai, N., Shibaguchi, T., Nishimoto, N., and Ohira, Y. (2014) Anti-interleukin-6 receptor antibody (MR16-1) promotes muscle regeneration via modulation of gene expressions in infiltrated macrophages, Biochim. Biophys. Acta, 1840, 3170–3180.
Suzuki, M., Bi, Y., Yoshida, H., Tanaka, K., Hashizume, M., and Matsumoto, Y. (2015) THU0061. The effect of anti-IL-6 receptor antibody on cartilage destruction in a mouse model of collagen-induced arthritis, Ann. Rheum. Dis., 74, 211–214.
Haffnerluntzer, M., Heilmann, A., Rapp, A. E., Beie, S., Schinke, T., Amling, M., Ignatius, A., and Liedert, A. (2013) Midkine-deficiency delays chondrogenesis during the early phase of fracture healing in mice, PLoS One, 9, e116282–e116282.
Livak, K. J., and Schmittgen, T. D. (2001) Analysis of rela-tive gene expression data using real-time quantitative PCR and the 2(–ΔΔC(T)) method, Methods, 25, 402–408.
Appelman-Dijkstra, N. M., and Papapoulos, S. E. (2015) Modulating bone resorption and bone formation in oppo-site directions in the treatment of postmenopausal osteoporosis, Drugs, 75, 1049–1058.
Jungbluth, P., Hakimi, A. R., Grassmann, J. P., Schneppendahl, J., Betsch, M., Kropil, P., Thelen, S., Sager, M., Herten, M., and Wild, M. (2013) The early phase influence of bone marrow concentrate on metaphyseal bone healing, Injury, 44, 1285–1294.
Tsangari, H., Findlay, D. M., Kuliwaba, J. S., Atkins, G. J., and Fazzalari, N. L. (2004) Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck, Bone, 35, 334–342.
Sun, T., Wang, X., Liu, Z., Chen, X., and Zhang, J. (2011) Plasma concentration of pro-inflammatory cytokines and outcome prediction in elderly hip fracture patients, Injury, 42, 707–713.
Heino, T. J., Timlin, S., Sederquist, B., and Aro, H. (2012) Different profiles of circulating sclerostin, IL-6 and TNF-alpha after hip fracture, Bone, 50, S120.
Rincon, M., and Irvin, C. G. (2011) Role of IL-6 in asthma and other inflammatory pulmonary diseases, Int. J. Biol. Sci., 8, 1281–1290.
Liu, X. H., Kirschenbaum, A., Yao, S., and Levine, A. C. (2006) The role of the interleukin-6/gp130 signaling pathway in bone metabolism, Vitam. Horm., 74, 341–355.
Chung, U., Schipani, E., McMahon, A. P., and Kronenberg, H. M. (2001) Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development, J. Clin. Invest., 107, 295–304.
Kugimiya, F., Kawaguchi, H., Kamekura, S., Chikuda, H., Ohba, S., Yano, F., Ogata, N., Katagiri, T., Harada, Y., and Azuma, Y. (2005) Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation, J. Biol. Chem., 280, 35704–35712.
Mi, M., Jin, H., Wang, B., Yukata, K., Sheu, T.-J., Ke, Q. H., Tong, P., Im, H.-J., Xiao, G., and Chen, D. (2013) Chondrocyte BMP2 signaling plays an essential role in bone fracture healing, Gene, 512, 211–218.
Yang, X., Ricciardi, B. F., Hernandez-Soria, A., Shi, Y., Pleshko, C. N., and Bostrom, M. P. (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice, Bone, 41, 928–936.
Wallace, A., Cooney, T. E., Englund, R., and Lubahn, J. D. (2011) Effects of interleukin-6 ablation on fracture healing in mice, J. Orthop. Res., 29, 1437–1442.
Wu, A. C., Raggatt, L. J., Alexander, K. A., and Pettit, A. R. (2013) Unraveling macrophage contributions to bone repair, Bonekey Rep., 2, 373.
Dreger, T., Watson, J. T., Dvm, W. A., Molligan, J., Achilefu, S., Schon, L. C., and Zhang, Z. (2014) Intravenous application of CD271-selected mesenchymal stem cells during fracture healing, J. Orthop. Trauma, 28 (Suppl. 1), S15.
Rezaee, F., Rellick, S. L., Piedimonte, G., Akers, S. M., O’Leary, H. A., Martin, K., Craig, M. D., and Gibson, L. F. (2010) Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway, PLoS One, 5, e9690.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, L., Liu, S., Song, T. et al. Blockade of interleukin 6 by rat anti-mouse interleukin 6 receptor antibody promotes fracture healing. Biochemistry Moscow 82, 1193–1199 (2017). https://doi.org/10.1134/S0006297917100121
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297917100121